We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $131M
1-Year Est. Return 86.64%
This Fund
S&P 500
This Quarter Est. Return
+25.62%
1 Year Est. Return
+86.64%
3 Year Est. Return
+281.25%
5 Year Est. Return
+337.18%
10 Year Est. Return
–
AUM
$131M
AUM Growth
+$10.2M
Cap. Flow
+$1.79M
Cap. Flow %
1.36%
Top 10 Hldgs %
82.43%
Holding
25
New
1
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
HELP
Cybin Inc
HELP
+$2.64M
2
CHYM
Chime Financial
CHYM
+$409K

Top Sells

Rank Stock Value
1
OCS icon
Oculis Holding
OCS
+$1.14M
2
BOLT icon
Bolt Biotherapeutics
BOLT
+$114K

Sector Composition

Rank Sector Weight
1 Healthcare 97.16%
2 Technology 1.97%
3 Miscellaneous 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MPLT
1
MapLight Therapeutics
MPLT
$639M
$34.8M 26.47%
971,253
– –
LBRX
2
LB Pharmaceuticals
LBRX
$1.59B
$20.5M 15.57%
630,657
– –
EVMN
3
Evommune Inc
EVMN
$445M
$19.2M 14.57%
1,441,032
– –
HELP
4
Cybin Inc
HELP
$893M
$6.53M 4.96%
987,222
+527,222
+115% +$2.64M
INCY icon
5
Incyte
INCY
$25.7B
$6.09M 4.63%
53,742
– –
RYTM icon
6
Rhythm Pharmaceuticals
RYTM
$7.07B
$5.45M 4.15%
49,120
– –
ONC
7
BeOne Medicines Ltd
ONC
$40.5B
$4.48M 3.41%
15,722
– –
OCS icon
8
Oculis Holding
OCS
$676M
$4.17M 3.17%
300,565
-50,180
-14% -$1.14M
ASND icon
9
Ascendis Pharma A/S
ASND
$17.7B
$3.63M 2.76%
13,600
– –
RVMD icon
10
Revolution Medicines
RVMD
$45B
$3.61M 2.74%
19,253
– –
KYMR icon
11
Kymera Therapeutics
KYMR
$9.76B
$3.54M 2.69%
30,875
– –
MDGL icon
12
Madrigal Pharmaceuticals
MDGL
$12.5B
$3.05M 2.32%
5,672
– –
CELC icon
13
Celcuity
CELC
$4.68B
$2.96M 2.25%
28,300
– –
ACAD icon
14
Acadia Pharmaceuticals
ACAD
$4.83B
$2.61M 1.98%
102,984
– –
ARGX icon
15
argenx
ARGX
$64.6B
$2.6M 1.98%
2,800
– –
RXRX icon
16
Recursion Pharmaceuticals
RXRX
$1.95B
$2.18M 1.66%
595,287
– –
PCOR icon
17
Procore
PCOR
$8.81B
$2.17M 1.65%
53,299
– –
HRMY icon
18
Harmony Biosciences
HRMY
$2.46B
$985K 0.75%
27,049
– –
INSM icon
19
Insmed
INSM
$27.6B
$702K 0.53%
6,580
– –
ETHA
20
iShares Ethereum Trust ETF
ETHA
$8.32B
$601K 0.46%
50,549
– –
IBIT icon
21
iShares Bitcoin Trust
IBIT
$61.8B
$532K 0.4%
15,968
– –
CHYM
22
Chime Financial
CHYM
$12.8B
$432K 0.33%
+21,075
New +$409K
RANI icon
23
Rani Therapeutics
RANI
$99.9M
$375K 0.29%
493,584
– –
TRDA icon
24
Entrada Therapeutics
TRDA
$278M
$361K 0.27%
49,082
– –
BOLT icon
25
Bolt Biotherapeutics
BOLT
$7.51M
$19.3K 0.01%
5,000
-24,250
-83% -$114K

Similar funds

FCM
Floyd Capital Management Texarkana, Texas $132M AUM 20.87% 1-Year Est. Return
NI
Nest Investments Conshohocken, Pennsylvania $132M AUM
WIM
Waycross Investment Management Bellingham, Washington $131M AUM 16.58% 1-Year Est. Return
UAML
US Asset Management LLC Pittsburgh, Pennsylvania $131M AUM 39.74% 1-Year Est. Return
EWL
Emissary Wealth LLC Hackensack, New Jersey $131M AUM
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
LMFP
Larry Mathis Financial Planning Phoenix, Arizona $131M AUM
KF
Kelsey Financial Moorpark, California $132M AUM

Nan Fung Group Holdings's Q2 2026 Portfolio in Review

As of Q2 2026, Nan Fung Group Holdings held 25 positions worth $131M, up 8.4% from $121M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 4%. Nan Fung Group Holdings opened 1 new position and made no exits, leaving the 25-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier, followed by Technology and Miscellaneous.

  • Nan Fung Group Holdings's largest Q2 2026 buy was Chime Financial: 21,075 shares worth $432K.
  • Nan Fung Group Holdings added most to Cybin Inc in Q2 2026, an estimated $2.64M increase.
  • Nan Fung Group Holdings's biggest Q2 2026 reduction was Oculis Holding, cutting an estimated $1.14M.
  • Nan Fung Group Holdings's ten largest holdings make up 82% of its $131M portfolio in Q2 2026.
  • Nan Fung Group Holdings opened 1 new position and closed 0 in Q2 2026.
  • Nan Fung Group Holdings's portfolio value rose 8.4% quarter-over-quarter to $131M.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.